Results from the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 2:28 2 years ago 110 Скачать Далее
Latest results from the CARTITUDE-2 trial of cilta-cel in progressive multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:33 2 years ago 120 Скачать Далее
An update on cohort C from the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 2:01 1 year ago 178 Скачать Далее
Updated Data from CARTITUDE-1 and CARTITUDE-2 Studies Testing Cilta-Cel in R/R Multiple Myeloma CheckRare 3:37 1 year ago 374 Скачать Далее
CARTITUDE-2 trial update and management of neurotoxicities VJHemOnc – Video Journal of Hematology & HemOnc 4:40 3 years ago 42 Скачать Далее
Latest Results from the CARTITUDE-2 Study Testing Cilta-cel in Multiple Myeloma Patients CheckRare 5:34 2 years ago 200 Скачать Далее
CARTITUDE-2 update: cilta-cel in relapsed and lenalidomide-refractory patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:45 1 year ago 57 Скачать Далее
ASH23: CARTITUDE-2 Trial on Ciltacabtagene Autoleucel in Multiple Myeloma | Jens Hillengass, MD, PhD International Myeloma Foundation 6:54 7 months ago 231 Скачать Далее
Updated Results from CARTITUDE-1: Phase 1b/2Study of Cilta-Cel in Pts With RR Multiple Myeloma International Myeloma Foundation 4:25 2 years ago 450 Скачать Далее
CARTITUDE-2: Ciltacabtagene autoleucel in patients with progressive multiple myeloma ecancer 7:41 2 years ago 91 Скачать Далее
An update on CARTITUDE-2: cilta-cel in patients with multiple myeloma in second line VJHemOnc – Video Journal of Hematology & HemOnc 1:21 2 years ago 94 Скачать Далее
CARTITUDE-2: evaluating CAR T therapy Cilta-Cel in multiple myeloma patients who had early relapse International Myeloma Foundation 5:03 2 years ago 340 Скачать Далее
CARTITUDE-2: Efficacy and safety of ciltacabtagene autoleucel in patients with progressive MM International Myeloma Foundation 7:23 3 years ago 382 Скачать Далее
Updated Results (2 years post-LPI) in Phase 1b/2 (CARTITUDE-1) Study of Cilta-Cel in RRMM patients International Myeloma Foundation 3:52 2 years ago 417 Скачать Далее
Neurologic adverse effects in pts with MM treated with cilta-cel in CARTITUDE-2 International Myeloma Foundation 9:34 3 years ago 223 Скачать Далее
Updates on Clinical Data of Cilta-Cel in CARTITUDE-2 Cohort A among Progressive MM patients International Myeloma Foundation 8:45 2 years ago 206 Скачать Далее
Final analysis of the DREAMM-2 trial: belantamab mafodotin for R/R multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 0:48 10 months ago 96 Скачать Далее
Cilta-cel in lenalidomide-refractory MM patients: updates from cohort A of the CARTITUDE-2 trial VJHemOnc – Video Journal of Hematology & HemOnc 3:07 2 years ago 193 Скачать Далее
Exciting CAR-T data in multiple myeloma and follicular lymphoma: CARTITUDE-2, ELARA & ZUMA-5 VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 76 Скачать Далее
Updated results from CARTITUDE-1 VJHemOnc – Video Journal of Hematology & HemOnc 1:07 2 years ago 149 Скачать Далее
